Cyclodextrins for growth of Helicobacter pylori and production of vacuolating cytotoxin. 1995

A Marchini, and M d'Apolito, and P Massari, and M Atzeni, and M Copass, and R Olivieri
IRIS, Biocine Immunobiological Research Institute Siena, Italy.

Growth of Helicobacter pylori in liquid culture requires the addition of media supplements that often interfere with subsequent purification of bacterial antigens. In order to determine whether cyclodextrins can substitute for conventional H. pylori growth supplements, we cultured H. pylori in the presence of five commercially available cyclodextrins. The effect of these compounds on the production of the vacuolating cytotoxin antigen was evaluated. Several cyclodextrins supported flourishing growth and permitted the consistent production of vacuolating cytotoxin. These data suggest that Brucella broth supplemented with cyclodextrins is an improved medium for bacterial culture and industrial production of H. pylori antigens.

UI MeSH Term Description Entries
D007218 Industrial Microbiology The study, utilization, and manipulation of those microorganisms capable of economically producing desirable substances or changes in substances, and the control of undesirable microorganisms. Microbiology, Industrial
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D003505 Cyclodextrins A homologous group of cyclic GLUCANS consisting of alpha-1,4 bound glucose units obtained by the action of cyclodextrin glucanotransferase on starch or similar substrates. The enzyme is produced by certain species of Bacillus. Cyclodextrins form inclusion complexes with a wide variety of substances. Cycloamylose,Cyclodextrin,Cyclodextrin Derivatives,Cyclomaltooligosaccharides,Derivatives, Cyclodextrin
D003603 Cytotoxins Substances that are toxic to cells; they may be involved in immunity or may be contained in venoms. These are distinguished from CYTOSTATIC AGENTS in degree of effect. Some of them are used as CYTOTOXIC ANTIBIOTICS. The mechanism of action of many of these are as ALKYLATING AGENTS or MITOSIS MODULATORS. Cytolysins,Cytotoxic Agent,Cytotoxic Agents,Cytotoxin,Agent, Cytotoxic
D000942 Antigens, Bacterial Substances elaborated by bacteria that have antigenic activity. Bacterial Antigen,Bacterial Antigens,Antigen, Bacterial
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae

Related Publications

A Marchini, and M d'Apolito, and P Massari, and M Atzeni, and M Copass, and R Olivieri
February 2002, Japanese journal of infectious diseases,
A Marchini, and M d'Apolito, and P Massari, and M Atzeni, and M Copass, and R Olivieri
April 1996, Molecular microbiology,
A Marchini, and M d'Apolito, and P Massari, and M Atzeni, and M Copass, and R Olivieri
November 1994, FEMS microbiology letters,
A Marchini, and M d'Apolito, and P Massari, and M Atzeni, and M Copass, and R Olivieri
August 2004, World journal of gastroenterology,
A Marchini, and M d'Apolito, and P Massari, and M Atzeni, and M Copass, and R Olivieri
January 2010, The Tohoku journal of experimental medicine,
A Marchini, and M d'Apolito, and P Massari, and M Atzeni, and M Copass, and R Olivieri
August 2003, Science (New York, N.Y.),
A Marchini, and M d'Apolito, and P Massari, and M Atzeni, and M Copass, and R Olivieri
September 2016, Translational cancer research,
A Marchini, and M d'Apolito, and P Massari, and M Atzeni, and M Copass, and R Olivieri
December 2004, Journal of biochemistry,
A Marchini, and M d'Apolito, and P Massari, and M Atzeni, and M Copass, and R Olivieri
February 2002, Nihon rinsho. Japanese journal of clinical medicine,
A Marchini, and M d'Apolito, and P Massari, and M Atzeni, and M Copass, and R Olivieri
May 1996, The Journal of cell biology,
Copied contents to your clipboard!